Correlation Between Seres Therapeutics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Seres Therapeutics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Zentalis Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Zentalis Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and Zentalis is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.03 times less return on investment than Zentalis Pharmaceuticals. In addition to that, Seres Therapeutics is 1.12 times more volatile than Zentalis Pharmaceuticals Llc. It trades about 0.05 of its total potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about 0.06 per unit of volatility. If you would invest 306.00 in Zentalis Pharmaceuticals Llc on August 28, 2024 and sell it today you would earn a total of 42.00 from holding Zentalis Pharmaceuticals Llc or generate 13.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
Seres Therapeutics |
Zentalis Pharmaceuticals |
Seres Therapeutics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Zentalis Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Scpharmaceuticals | Zentalis Pharmaceuticals vs. Milestone Pharmaceuticals | Zentalis Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |